chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 67-year-old male patient received BNT162b2 (COMIRNATY), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "arrhythmia" (unspecified if ongoing); "heart disease" (unspecified if ongoing); "cardiomyopathy" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Comirnaty (DOSE 1, SINGLE), for Covid-19 immunization, reaction(s): "loss of appetite", "he did not have a good experience with this initial series like not a good flu and kept me out of work for the whole week", "for 3 or 4 days lethargic/Couldn't do much", "Couldn't do much/ stayed around home", "nasty for 3 or 4 days". The following information was reported: MALAISE (non-serious), outcome "recovered", described as "nasty for 3 or 4 days"; DECREASED APPETITE (non-serious), outcome "recovered", described as "loss of appetite"; LETHARGY (non-serious), outcome "recovered", described as "for 3 or 4 days lethargic/Couldn't do much"; INFLUENZA (non-serious), outcome "recovered", described as "he did not have a good experience with this initial series like not a good flu and kept me out of work for the whole week"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "recovered", described as "Couldn't do much/ stayed around home". Additional information: The patient would be 68 in a month. The patient has cardiomyopathy, arrhythmia and was on different medications because of these conditions. The patient was little concerned because of getting more shots. The patient did not visit his cardiologist about the next shot. Cardiologist was adamant about him getting the first shots because of his malady. The patient was more skeptical going forward. It was reported as since Comirnaty is new and not tested properly the patient was a little concerned with his maladies. When the time came the patient got first two shots and didn't go with booster because didn't had good reactions to first two shots. Not terrible, just felt nasty for 3 or 4 days.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-202201104375 Same patient/drug/event, different events;
0.5ml Td vaccine given IM to Left deltoid on 2/12/04 after patient revealed she had not had Td booster since 1985. Pt seen again 2/18/04 stating she was having a "reaction" to Td injection. Pt c/o increasing pain,arm swelling, weakness to L arm from shoulder to elbow which began 2/15/04 and has continued to worsen resulting in L arm abduction restricted to 90 degrees due to pain. On exam L arm was without obvious swelling, no redness or warmth, tender to touch, abduction > 90 degrees caused pain. Strength to bil arms was weak but equal. Pt states she had taken ES tylenol without relief.
I received my 1st dosage of the Pfizer shot on April 5th 2021 and my 2nd dosage on 27 APR 2021, both at the medical cente. Starting around mid August, I started feeling and suffering from Myocarditis and Pericarditis and thus having heart palpitations. This has affected me on a daily basis....and on a nightly basis, preventing me from getting a full night's rest. I usually sleep every night around 4 hours, due to the fact that I am always waking up due to my abnormal breathing. On a daily basis, I have been affected by: changing in breathing, little difficult in breathing, being out of breath, pounding heart, feelings of enlarged heart, shortness of breath, being tired and needing to take a break throughout the day. Please note that even though I suffer from these conditions for a couple of months now, nothing has been too severe whereas I feel like I need immediate medical attention.
Patient received partial dose of Jynneos Smallpox-Monkeypox vaccine as 2nd dose in the two dose series. A small portion of the ID injection created a tiny wheal in the patient forearm, and the remaining portion leaked from injection site and needle. Per CDC recommendations and patient permission, another dose of the vaccine was immediately administered approximately one inch from the failed injection site. No other issues with vaccine administration. Patient instructed to notify PCP and writer if there are any side effects or concerns.
Patient was given Moderna Booster Vaccine instead of Flulaval vaccine, but patient wanted to get both at the end. Moderna was given by mistake but patient was due for a booster vaccine, had previously received Pfizer 2 doses, last dose in 04/2021.
Localized area on left arm approx 3 in in diameter hot red and irritated also hard
Right upper thigh with redness and swelling. Dx with cellulitis. Bactraban TID, Duricef 500/5ml, 1 tsp BID for 10 days. Cold compress 2 times for 1 day.
This spontaneous report as received from a pharmacist refers to a 51 year old male patient with no drug reactions or allergies. On 07-JUL-2014, the patient was vaccinated with ZOSTAVAX (lot # J011830, exp. date 26-DEC-2014, dose 0.65 ml, subcutaneous). On 07-JUL-2014, later that day that ZOSTAVAX was administered, the patient experienced swelling and redness at injection site. The pharmacist was informed by the patient that the redness was about the size of a baseball. The patient called in to the pharmacy on 09-JUL-2014 to inform the pharmacy what he developed. She also stated that the patient was seen by his physician on the same day. No treatment was given for the events and there were no laboratory diagnostic studies performed. The outcome of the events was reported as not recovered. The relatedness between the events and therapy with ZOSTAVAX was not provided. Additional information has been requested.
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment details were not provided.
Rash - varicella. Treatment recommended calamine, BENADRYL, oatmeal bath.
had period Late February/Early March, received first dose on 3/31/2021, had very light spotting 4/1/2021 and have not gotten period since.
Immediately developed Lymphedema in both legs with walking difficulties 4 days after the COVID vaccination was administered.
Headache, Arthralgia, Fever, pain at injection site, chills, fatigue Narrative:
Not feeling good; headache; chills; kind of fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling good), HEADACHE (headache), CHILLS (chills) and PYREXIA (kind of fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced MALAISE (Not feeling good), HEADACHE (headache), CHILLS (chills) and PYREXIA (kind of fever). On 21-Jan-2021, MALAISE (Not feeling good), HEADACHE (headache), CHILLS (chills) and PYREXIA (kind of fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I tested positive for covid on 09Jan2021; I tested positive for covid on 09Jan2021; Fatigue, sore arm up to 48 hours post injection. Started feeling feverish with chills on 03Jan2021. I tested positive for covid on 09Jan2021; Fatigue, sore arm up to 48 hours post injection. Started feeling feverish with chills on 03Jan2021. I tested positive for covid on 09Jan2021; Fatigue, sore arm up to 48 hours post injection. Started feeling feverish with chills on 03Jan2021. I tested positive for covid on 09Jan2021; Fatigue, sore arm up to 48 hours post injection. Started feeling feverish with chills on 03Jan2021. I tested positive for covid on 09Jan2021; This is a spontaneous report from a contactable nurse.  A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number EK5730), intramuscular in Left arm on 30Dec2020 17:00 at single dose for covid-19 immunisation.  Medical history included asthma (as a child).  Concomitant medication included loratadine (CLARITIN [LORATADINE]), cyanocobalamin (B12 [CYANOCOBALAMIN]), fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]). The patient previously took morphine and experienced Known allergies. The patient experienced fatigue, sore arm up to 48 hours post injection. Started feeling feverish with chills on 03Jan2021. I tested positive for covid on 09Jan2021. The patient received just fluids, vit c,zinc, and vitd as treatment. No covid prior vaccination. Covid tested post vaccination. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 09Jan2021, sars-cov-2 test: positive on 07Jan2021. The outcome of the event Feverish and Chills was resolved on Jan2021, Vaccination site pain and Fatigue was resolved on an unspecified date, while the outcome of the other events was unknown.
Employee who works in Dental school received MMR vaccinatioin on 5/20/2009. Screening questions asked regarding pregnancy or plans to become pregnant which were No at the time of vaccine.  Employee returns 7/17/2009 for #2 MMR and states she is pregnant and may have been pregnant sometime between May 10- May 20th.  Second MMR not given.  Employee is under care of OB/GYN. She was advised to discuss this with her OB .
Patient received Zoster Vaccine 0.65ml in clinic and developed above described side effects. The patient received treatment in the ER and was subsequently discharged from ER to home. Patient symptoms eventually resolved. Rash and nausea, shortness of breath, sores on lips.
More than 36 days since he got the first dose and still does not have the second; he has contracted COVID and tested positive; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (he has contracted COVID and tested positive) and PRODUCT DOSE OMISSION ISSUE (More than 36 days since he got the first dose and still does not have the second) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced COVID-19 (he has contracted COVID and tested positive). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days since he got the first dose and still does not have the second). At the time of the report, COVID-19 (he has contracted COVID and tested positive) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (More than 36 days since he got the first dose and still does not have the second) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Aug-2021, SARS-CoV-2 test: positive (Positive) tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was stated that two days before he was due for his second dose. It was now been two weeks since he was  tested positive and he wants to come back and get his second dose.   No concomitant medication was reported. No treatment history was reported.
The pt felt weakness, headache, diaphoresis following the vax. The pt was still not well on the following day. It was suggested that she call her MD.
Initial arm soreness, followed 3 days later with severe joint pain and swelling in both wrists, fingers, shoulders, knees, neck, feet, hips.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. During 2010, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. During 2016, the patient was treated by a physician and was diagnosed with herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX, for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Nausea; This is a spontaneous report from a contactable Nurse (patient) via Pfizer sales representative. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown) via an unspecified route of administration on an unspecified date as a single dose for Covid-19 immunization. The patient's medical history and concomitant medications wee not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE). Pfizer representative stated, "I was talking to one of my Nurses and she had a COVID vaccine. She was telling me. She had nausea after I think her second shot on an unspecified date. She had said first shot was fine. You know her second shot she had a little nausea afterwards. It wasn't a big deal." The outcome of the event was unknown.  Information on the Lot/Batch number has been requested.
This spontaneous report sa received from other health professional refers to a female patient of unknown age. Medical history and concomitant medications were not reported. On 05-MAY-2014, the patient was vaccinated with LIQUID PEDVAXHIB (U4423HD) (manufacturer also reported as Sanofi Pasteur) in the left arm. Concomitant medications were not reported. The patient was administered vaccines stored at inappropriate temperature (out of range temp logs). The outcome was unknown. Additional information has been requested.
Approximately 4 hours after injection of rabies vaccine patient noted rash on chest after getting out of shower-patient stated it was itching-and developed difficulty breathing-no throat, tongue or mouth swelling. Responded to treatment at ER.
14 y/o female was in Clinic for immunizations Wednesday evening at 8PM on 1/20/2016. She denied reactions to previous vaccine, heart and lungs sounds were normal, and she was afraid. Approximately 15 minutes after giving last of four vaccines (HPV, Varicella, Hepatitis A, Influenza and PPD). Patient started shivering, she was covered, provider asked mother to stay at her side, and provider checked on her approximately 4 times in the 15 minutes. Patient started complaining of shortness of breath and difficulty speaking. Provider then administered oxygen via nasal cannula at 4LPM. Symptoms improved somewhat but patient was still shivering and complaining of constriction in her throat. Provider asked medical assistant to call 911 at approximately 8:55 Pm. Fire paramedics arrived approximately 9:05pm, assessed patient, and they gave her Benadryl 50 mg, loaded patient on Gurney, transported to hospital.
pt called 3 days after the vaccine and complained about muscle aches and weakness all over body. have no problem with previous shots
REDNESS FROM NECK TO BELLY, WARM TO TOUCH THAT WAS SELF LIMITING AND LASTED ROUGHLY 24 HOURS
Information has been received from a mother concerning her 24 year old daughter who in May 2008 was vaccinated with the first dose of GARDASIL vaccine (yeast), injection form, (Lot # was not available). Concomitant therapy included hormonal contraceptives (unspecified). In approximately May 2008, 2 to 3 weeks after receiving the first dose of GARDASIL vaccine (yeast) the patient developed warts on her hand. The patient's warts on hand persisted. The patient sought medical attention of a dermatologist. Additional information has been requested.
100.4 Fever, Injection site pain, tiredness, headache, muscle pain, chills, joint pain, feeling unwell and weakness. Started this morning around 9am. Got worse over the day. She did her dialysis cause she needed it. That makes her weak sometimes but she doesn't get any of the other symptoms from dialysis. Her vaccination shot was yesterday.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in an 18-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2022 at 11:20 AM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 12-Feb-2022 at 11:20 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was reported.  Patient received vaccine past its 30 day expiry date. Vaccine went into 2 to 8 degree celsius thaw state on or about 24-Dec-2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. Reporter no longer possessed this lot number.  No treatment medication was provided.   This case was linked to MOD-2022-542869 (Patient Link).
Red rash size of tennis ball, sore, warm to touch. Called the next day, took one BENADRYL on 10/01/2018 and rash was smaller and not as sore.
Rrash at the site of injection; Rash at right side of neck; This case was reported by a physician via sales rep and described the occurrence of injection site rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2022, the patient received Shingrix. In August 2022, less than a week after receiving Shingrix, the patient experienced injection site rash and rash. On an unknown date, the outcome of the injection site rash and rash were unknown.   It was unknown if the reporter considered the injection site rash and rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 22-AUG-2022 Reporter's Comment: The reporter was a physician. The GSK representative was reporting on behalf of Healthcare professional(HCP). The patient received dose of Shingrix on her left arm a week ago and rash had appeared at the site of the injection as well as on the right side of her neck. The reporter consented to follow up.
pt recvd flu vax & devel sudden onset of hypotension, hypoglycemia & chills; pt suffered a cardiac arrest & was hospitalized & died;
chills; Fatigue; slight fever; chills; fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of CHILLS (chills), the second episode of CHILLS (chills), FATIGUE (fatigue), PYREXIA (fever) and PYREXIA (slight fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced the first episode of CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever). On 26-Mar-2021, the patient experienced PYREXIA (slight fever). On 28-Mar-2021, the patient experienced the second episode of CHILLS (chills) and FATIGUE (Fatigue). On 07-Mar-2021, FATIGUE (fatigue) and PYREXIA (fever) had resolved. On 26-Mar-2021, PYREXIA (slight fever) had resolved. On 28-Mar-2021, last episode of CHILLS (chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Reported onset of Cough, fatigue, weakness  8/4/2022 Admitted to  8/112022 to  MEDICAL CENTER  Submitter does not have access to further medical records or information on hospital course. If further information is needed, please contact  the Medical center as noted above.